TTAX03 (CRYOPRESERVED AMNIOTIC MEMBRANE AND CRYOPRESERVED UMBILICAL CORD)
Knee Pain Chronic
BioTissue Holdings, Incother_biologicalPhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
13 Active assets in the Knee Pain Chronic cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ROPIVACAINE Poznan University of Medical Sciences | Phase 4 | BBB |
DEXAMETHASONE Poznan University of Medical Sciences | Phase 4 | BBB |
Bxcl501 Poznan University of Medical Sciences | Phase 4 | BB |
VENLOR University of California, San Francisco | Phase 4 | BB |
Lopain Sorrento Therapeutics, Inc. | Phase 3 | BB |
View all 22 →
Same molecule, other indications
TTAX03 (CRYOPRESERVED AMNIOTIC MEMBRANE AND CRYOPRESERVED UMBILICAL CORD) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →